Jarron Tilghman, MD
Pain Medicine · Lees Summit, MONPI 1497997423
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Vertiflex, Inc. at 50.1% of the total. Reporting peaked in 2019 at $2,107 and has fallen 83.6% since, to $345 in 2025.
Across 62 payments — averaging $63.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$2K
- Nalu Medical, Inc.$877
- Abbott$676
- Tenex Health Inc.$174
- Stryker$138
- Pacira Pharmaceuticals Incorporated$25
- plus $66 from 3 others
What the payments were for
- Travel & lodging$2,30859%
- Food & beverage$1,60841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 16 | $1,960 |
| Nalu Medical, Inc. | 8 | $877 |
| Abbott | 28 | $676 |
| Tenex Health Inc. | 1 | $174 |
| Stryker | 4 | $138 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Vericel Corporation | 1 | $24 |
| Pfizer | 2 | $23 |
| Vertex | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,679
- Nalu Neurostimulation System$651
- PROCLAIM$122
How this compares
$3,916 in reported general payments places this provider in the 55th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 269 | $2,859 |
| Cyclobenzaprine Hcl | 137 | $1,352 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 145 | $1,218 |
| Methocarbamol | 66 | $790 |
| Methylprednisolone | 91 | $636 |
| Ibuprofen | 57 | $366 |
| Celecoxib | 15 | $352 |
| Pregabalin | 19 | $280 |
| Tizanidine Hcl | 54 | $267 |
| Nabumetone | 17 | $255 |
| Diclofenac Sodium | 11 | $195 |
| Tramadol Hcl | 66 | $168 |
| Oxycodone Hcl | 21 | $154 |
| Meloxicam | 31 | $119 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lees Summit
- Nicholas DonohueLees Summit$15K
- James ScowcroftLees Summit$7K
- Morgan GonderLees Summit$6K
- Joel AckermanLees Summit$5K
- Mark ChaplickLees Summit$4K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.